Elite Health Systems Inc.: 10-Q filed 2012-08-14

Name: Elite Health Systems Inc.: 10-Q filed 2012-08-14
Creator: Elite Health Systems Inc.

What Elite Health Systems Inc. reported in its quarterly report filed 2012-08-14 (fiscal Q2 2012): 18 published measures, 48 facts as tagged in accession 0001140361-12-036761.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-08-14
Fiscal period: fiscal Q2 2012
Accession: 0001140361-12-036761 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Elite Health Systems Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	3,934,000	USD
At 2011-12-31	4,165,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-06-30	2,543,000	USD
At 2011-12-31	2,826,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	1,391,000	USD
At 2011-12-31	1,339,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	956,000	USD
At 2011-12-31	830,000	USD
At 2011-06-30	1,036,000	USD
At 2010-12-31	820,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-11,000	USD	91
2012-01-01 to 2012-06-30	51,000	USD	182
2011-04-01 to 2011-06-30	106,000	USD	91
2011-01-01 to 2011-06-30	32,000	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	390,000	USD	182
2011-01-01 to 2011-06-30	595,000	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	0	USD	182
2011-01-01 to 2011-06-30	89,000	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	-1,788,000	USD
At 2011-12-31	-1,839,000	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-06-30	2,080,000	USD
At 2011-12-31	2,336,000	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	39,000	USD	91
2012-01-01 to 2012-06-30	150,000	USD	182
2011-04-01 to 2011-06-30	173,000	USD	91
2011-01-01 to 2011-06-30	229,000	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	1,524,000	USD
At 2011-12-31	1,358,000	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	57,000	USD	91
2012-01-01 to 2012-06-30	116,000	USD	182
2011-04-01 to 2011-06-30	67,000	USD	91
2011-01-01 to 2011-06-30	136,000	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	571,000	USD
At 2011-12-31	563,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-06-30	378,000	USD
At 2011-12-31	313,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	430,000	USD	91
2012-01-01 to 2012-06-30	914,000	USD	182
2011-04-01 to 2011-06-30	375,000	USD	91
2011-01-01 to 2011-06-30	815,000	USD	181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	210,000	USD	91
2012-01-01 to 2012-06-30	488,000	USD	182
2011-04-01 to 2011-06-30	226,000	USD	91
2011-01-01 to 2011-06-30	488,000	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	256,000	USD	182
2011-01-01 to 2011-06-30	405,000	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	65,000	USD	182
2011-01-01 to 2011-06-30	-202,000	USD	181

Inspect the source

Entity: Elite Health Systems Inc. / CIK 0001089815
Captured: 2026-09-20T05:21:39.780Z
SEC response SHA-256: 945f4816b81154e3435cea1e5a5dd44d20bcc6184a9c9d4e1800c05501271990

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001089815.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))